Show simple item record

dc.contributor.authorÇağlar, Seda
dc.contributor.authorBüyükyılmaz, Funda
dc.contributor.authorCoşansu, Gülhan
dc.contributor.authorÇağlayan, Sabiha
dc.date.accessioned10.07.201910:49:13
dc.date.accessioned2019-07-10T20:01:27Z
dc.date.available10.07.201910:49:13
dc.date.available2019-07-10T20:01:27Z
dc.date.issued2017en_US
dc.identifier.citationÇağlar, S., Büyükyılmaz, F., Coşansu, G. ve Çağlayan, S. (2017). Effectiveness of shotblocker for immunization pain in full-term neonates a randomized controlled trial. Journal of Perinatal & Neonatal Nursing, 31(2), 166-171. https://dx.doi.org/10.1097/JPN.0000000000000256en_US
dc.identifier.issn0893-2190
dc.identifier.issn1550-5073
dc.identifier.urihttps://dx.doi.org/10.1097/JPN.0000000000000256
dc.identifier.urihttps://hdl.handle.net/20.500.12511/3279
dc.descriptionWOS: 000400615400013en_US
dc.descriptionPubMed ID: 28437308en_US
dc.description.abstractNonpharmacologic strategies exist to manage procedural pain in healthy newborn infants. The aim of this prospective randomized controlled trial (RCT) was to examine the efficacy of ShotBlocker for managing injection pain associated with the first intramuscular hepatitis B vaccine given to healthy full-term neonates. This randomized controlled trial study was conducted in a private university hospital in Istanbul, Turkey, in which 100 healthy term neonates were randomly assigned to either a ShotBlocker (n = 50) or control group (n = 50). The Neonatal Infant Pain Scale scores of the neonates in the ShotBlocker and control groups were compared before, during, and after the injections, and the physiological parameters were compared before and after the procedure. The pain scores of the neonates during (ShotBlocker group: 1.64 +/- 0.80; control group: 2.96 +/- 0.73) and after (ShotBlocker group: 0.74 +/- 0.66; control group: 1.42 +/- 0.76) the injection procedure were lower in the ShotBlocker group than in the control group (P =.000). The postinjection heart rate in the infants in the ShotBlocker group (145.02 +/- 13.50) was found to be lower than in those for whom ShotBlocker was not used (150.24 +/- 13.36) (P =.05). The use of ShotBlocker during the hepatitis B vaccine in term neonates is effective in reducing the acute pain.en_US
dc.language.isoengen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.rightsinfo:eu-repo/semantics/embargoedAccessen_US
dc.subjectFull-Term Neonatesen_US
dc.subjectInjection Painen_US
dc.subjectIntramuscular Injectionen_US
dc.subjectShotBlockeren_US
dc.titleEffectiveness of shotblocker for immunization pain in full-term neonates a randomized controlled trialen_US
dc.typearticleen_US
dc.relation.ispartofJournal of Perinatal & Neonatal Nursingen_US
dc.departmentİstanbul Medipol Üniversitesi, Sağlık Bilimleri Fakültesi, Hemşirelik Bölümüen_US
dc.identifier.volume31en_US
dc.identifier.issue2en_US
dc.identifier.startpage166en_US
dc.identifier.endpage171en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.doi10.1097/JPN.0000000000000256en_US
dc.identifier.wosqualityQ3en_US
dc.identifier.scopusqualityQ2en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record